Arctic Vision expands global reach with acquisition of MDCO Technology’s ophthalmic device business
By: IPP Bureau
Last updated : February 04, 2026 9:37 am
Arctic Vision (Cayman) Limited, a global leader in ophthalmology, has signed an agreement to acquire the ophthalmic device business of Hangzhou-based MDCO Technology.
The move brings MDCO’s cutting-edge intraocular lens (IOL), implantable contact lens (Phakic Lens), and refractive-device platforms into Arctic Vision’s global innovation framework, bolstering the company’s portfolio of advanced eye-care solutions.
The transaction positions Arctic Vision to accelerate ophthalmic innovation worldwide by combining MDCO’s design and manufacturing expertise with its own strengths in retinal, ocular surface, and neuro-ophthalmic R&D. The companies say the deal will create an industry-leading pipeline of therapeutic and device offerings for patients with high unmet needs.
Under the agreement, MDCO will become a wholly owned subsidiary of Arctic Vision, with operations retained across Shanghai (biopharmaceutical R&D, regulatory affairs, operations), Hangzhou (device R&D, manufacturing, commercial management), and California (design and global collaboration).
“This transaction represents a pivotal step for Arctic Vision’s long-term growth strategy,” said Dr Eddy Wu, Founder, Chairman and CEO of Arctic Vision.
“Through the integration of MDCO’s ophthalmic device platforms with Arctic Vision’s pharmaceutical innovation capabilities, we are establishing a truly comprehensive ophthalmic innovation ecosystem—one that integrates scientific excellence with advanced manufacturing and commercial scale. Looking ahead, we are building a company structurally prepared for broader global investment participation and future capital-market opportunities, while expanding our ability to reach more patients and deliver greater impact across the ophthalmology community worldwide.”
“Becoming part of Arctic Vision’s integrated platform opens a new chapter for MDCO,” said Liang Liu, Chairman of MDCO Technology. “MDCO’s hallmark intraocular and refractive products will benefit from Arctic Vision’s strong R&D and regulatory foundation, enabling accelerated development and broader market access worldwide.”